降压达标对高血压合并慢性肾脏病患者肾功能下降及首次卒中的影响
本研究纳入3230例轻中度慢性肾脏病合并高血压患者,随机接受依那普利10mg联合叶酸0.8mg或依那普利10mg单药治疗,随访中位4.7年。与时间平均收缩压135-≤140mmHg者相比,≤135mmHg者首次卒中及缺血性卒中风险显著降低;时间平均舒张压≤80mmHg者出血性卒中风险显著降低;收缩压≤130mmHg者CKD进展风险呈降低趋势但未达统计学显著性。
要点
- 时间平均收缩压≤135mmHg可降低首次卒中和缺血性卒中风险。
- 时间平均舒张压≤80mmHg与出血性卒中风险降低显著相关。
- 收缩压≤130mmHg对CKD进展的获益趋势未达统计学显著性。
核心结论
- 在轻中度CKD合并高血压患者中,治疗血压≤135/80mmHg较135-140/80-90mmHg可降低首次卒中风险。
研究设计与样本
- 本研究为随机对照试验的二次分析,纳入3230例估算肾小球滤过率30-60mL/min/1.73m2和/或蛋白尿的高血压患者。
- 参与者随机接受每日依那普利10mg联合叶酸0.8mg或依那普利10mg单药治疗,每3个月随访一次。
- 中位降压治疗时间为4.7年。
主要发现
- 与时间平均收缩压135-≤140mmHg者相比,≤135mmHg者总首次卒中发生率1.7%对3.3%,HR 0.51(95%CI 0.26-0.99)。
- 与时间平均收缩压135-≤140mmHg者相比,≤135mmHg者缺血性卒中发生率1.3%对2.8%,HR 0.46(95%CI 0.22-0.98)。
- 与时间平均舒张压80-≤90mmHg者相比,≤80mmHg者出血性卒中发生率0.2%对0.9%,HR 0.18(95%CI 0.04-0.80)。
- 与时间平均收缩压135-≤140mmHg者相比,≤130mmHg者CKD进展风险呈降低趋势但未达统计学显著性。
临床怎么用
- 对轻中度CKD合并高血压患者,可考虑将治疗血压控制在≤135/80mmHg以降低首次卒中风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of achieved blood pressure (BP) on first stroke and renal function decline among hypertensive patients with mild to moderate chronic kidney disease (CKD) is still uncertain. METHODS: In total, 3230 hypertensive patients with estimated glomerular filtration rate 30-60 mL/min/1.73 m2 and/or proteinuria were included in the present analyses. Eligible participants were randomly assigned to a daily treatment of a combined enalapril 10 mg and folic acid 0.8 mg tablet or an enalapril 10 mg tablet alone. Participants were followed up every 3 months. The study outcomes included first stroke and the progression of CKD. RESULTS: The median antihypertensive treatment duration was 4.7 years. Compared with participants with a time-averaged on-treatment systolic blood pressure (SBP) of 135 to ≤140 mmHg, the incidence of total first stroke [1.7% versus 3.3%; hazard ratio (HR), 0.51; 95% confidence interval (CI): 0.26-0.99] and ischemic stroke (1.3% versus 2.8%; HR, 0.46; 95% CI: 0.22-0.98) decreased significantly in those with a time-averaged SBP of ≤135 mmHg. Furthermore, a time-averaged diastolic blood pressure (DBP) of ≤80 mmHg, compared with a time-averaged DBP level of 80 to ≤90 mmHg, was significantly related to a decreased risk of hemorrhagic stroke (0.2% versus 0.9%; HR, 0.18; 95% CI: 0.04-0.80). However, compared with participants with a time-averaged SBP of 135 to ≤140 mmHg, a lower but non-significant trend of CKD progression was found in those with a time-averaged SBP of ≤130 mmHg. CONCLUSIONS: A BP treatment level of ≤135/80 mmHg, compared with a BP treatment level of 135-140/80-90 mmHg, could lead to a decreased risk of first stroke in hypertensive patients with mild-to-moderate CKD.
引用
- Li Y, Liang M, Jiang C, et al. Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease. Nephrol Dial Transplant. 2018. PMID: 29036427. doi:10.1093/ndt/gfx267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。